Which is the correct general toxicity for anti-metabolites chemotherapy?

WCL Staff Nurse - 2022

Pharmacology

Easy

Appeared in: WCL Staff Nurse - 2022

Explanation

Antimetabolites are cell cycle-specific drugs that primarily act during the S-phase (DNA synthesis).
They exert their cytotoxic effects on rapidly dividing cells.
The bone marrow contains some of the most rapidly proliferating cells in the body, making it highly susceptible to these drugs.
This leads to bone marrow suppression (myelosuppression), which manifests as neutropenia, anemia, and thrombocytopenia.
Myelosuppression is the most common and the primary dose-limiting toxicity for the antimetabolite class.

Option B: While stomatitis (inflammation and sores in the mouth) is a very common side effect of antimetabolites due to the high turnover of mucosal cells, it is generally not considered the primary dose-limiting or most significant general toxicity compared to the life-threatening risks of bone marrow suppression.
Option C: Pulmonary toxicity is not a general characteristic of the antimetabolite class. It is the hallmark toxicity of other specific chemotherapy agents.
Option D: Neurotoxicity is not a general toxicity associated with antimetabolites. Certain agents can have neurotoxic effects (e.g., high-dose Cytarabine), but it is not a class-wide hallmark.

Clinical Relevance

Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Hallmark toxicity of antimetabolite chemotherapy as background academic context rather than a clinical decision trigger.
Nurses must prioritize monitoring the Complete Blood Count (CBC) for patients receiving antimetabolite chemotherapy, with special attention to the Absolute Neutrophil Count (ANC), platelet count, and hemoglobin levels.
A low ANC (neutropenia) places the patient at high risk for life-threatening infections, requiring strict infection control measures (neutropenic precautions).
A low platelet count (thrombocytopenia) increases the risk of serious bleeding.

How to Approach the Question

This is a factual recall question common in pharmacology.
First, identify the specific drug class in the question: 'anti-metabolites'.
Recall the fundamental mechanism of this class: they interfere with DNA synthesis and primarily affect rapidly dividing cells.
Think about which tissues in the body have the highest rate of cell division: bone marrow, gastrointestinal lining, and hair follicles.
Evaluate the given options in this context. Bone marrow suppression is a direct, severe, and common consequence of this mechanism.
Differentiate this from other common side effects (like stomatitis) and from hallmark toxicities of other drug classes (pulmonary, neurotoxicity) to select the best answer for 'general toxicity'.

Concept Tested & Keywords

Qf7DaMsKchtIPxR8wzRvnW

E6 Pharmacology Nursing Lilley 11e Part 3 p. 82-84

E6 Pharmacology KD Tripathi Essentials 9e Part 3 p. 196-198